|
1
|
Wang Y, Huang Y, Chase RC, Li T, Ramai D,
Li S, Huang X, Antwi SO, Keaveny AP and Pang M: Global burden of
digestive diseases: A systematic analysis of the global burden of
diseases study, 1990 to 2019. Gastroenterology. 165:773–783.e15.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee M and Chang EB: Inflammatory bowel
diseases (IBD) and the microbiome-searching the crime scene for
clues. Gastroenterology. 160:524–537. 2021. View Article : Google Scholar
|
|
3
|
Mayerle J, Sendler M, Hegyi E, Beyer G,
Lerch MM and Sahin-Tóth M: Genetics, cell biology, and
pathophysiology of pancreatitis. Gastroenterology.
156:1951–1968.e1. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou WC, Zhang QB and Qiao L: Pathogenesis
of liver cirrhosis. World J Gastroenterol. 20:7312–7324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gordon-Weeks AN, Lim SY, Yuzhalin AE,
Jones K and Muschel R: Macrophage migration inhibitory factor: A
key cytokine and therapeutic target in colon cancer. Cytokine
Growth Factor Rev. 26:451–461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ku G, Tan IB, Yau T, Boku N, Laohavinij S,
Cheng AL, Kang YK and de Lima Lopes G Jr: Management of colon
cancer: Resource-stratified guidelines from the Asian Oncology
Summit 2012. Lancet Oncol. 13:e470–e481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lauriola M, Tomai M, Palma R, La Spina G,
Foglia A, Panetta C, Raniolo M and Pontone S: Intolerance of
uncertainty and anxiety-related dispositions predict pain during
upper endoscopy. Front Psychol. 10:11122019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Eisenberg E, Konopniki M, Veitsman E,
Kramskay R, Gaitini D and Baruch Y: Prevalence and characteristics
of pain induced by percutaneous liver biopsy. Anesth Analg.
96:1392–1396. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zedan AH, Hansen TF, Fex Svenningsen A and
Vilholm OJ: Oxaliplatin-induced neuropathy in colorectal cancer:
Many questions with few answers. Clin Colorectal Cancer. 13:73–80.
2014.
|
|
10
|
Click B and Regueiro M: A practical guide
to the safety and monitoring of new IBD therapies. Inflamm Bowel
Dis. 25:831–842. 2019. View Article : Google Scholar :
|
|
11
|
Cosnes J, Bourrier A, Laharie D, Nahon S,
Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, et
al: Early administration of azathioprine vs conventional management
of Crohn's Disease: A randomized controlled trial.
Gastroenterology. 145:758–765.e52; quiz e14-e55. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan K, Cao C, Pan Y, Lu D, Yang D, Feng J,
Song L, Liang M and Yan X: Magnetoferritin nanoparticles for
targeting and visualizing tumour tissues. Nat Nanotechnol.
7:459–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gazouli M, Bouziotis P, Lyberopoulou A,
Ikonomopoulos J, Papalois A, Anagnou NP and Efstathopoulos EP:
Quantum dots-bevacizumab complexes for in vivo imaging of tumors.
In Vivo. 28:1091–1095. 2014.PubMed/NCBI
|
|
14
|
Zhong Y, Ma Z, Wang F, Wang X, Yang Y, Liu
Y, Zhao X, Li J, Du H, Zhang M, et al: In vivo molecular imaging
for immunotherapy using ultra-bright near-infrared-IIb rare-earth
nanoparticles. Nat Biotechnol. 37:1322–1331. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Idris AO, Mabuba N and Arotiba OA: An
exfoliated graphite-based electrochemical immunosensor on a
dendrimer/carbon nanodot platform for the detection of
carcinoembryonic antigen cancer biomarker. Biosensors (Basel).
9:392019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li Y, Huang Z, Li Z, Li C, Liu R and Lv Y:
Mass spectrometric multiplex detection of MicroRNA and protein
biomarkers for liver cancer. Anal Chem. 94:17248–17254. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo J, Yu Z, Sun D, Zou Y, Liu Y and Huang
L: Two nanoformulations induce reactive oxygen species and
immunogenetic cell death for synergistic chemo-immunotherapy
eradicating colorectal cancer and hepatocellular carcinoma. Mol
Cancer. 20:102021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song W, Tiruthani K, Wang Y, Shen L, Hu M,
Dorosheva O, Qiu K, Kinghorn KA, Liu R and Huang L: Trapping of
lipopolysaccharide to promote immunotherapy against colorectal
cancer and attenuate liver metastasis. Adv Mater. 30:e18050072018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Manea F, Houillon FB, Pasquato L and
Scrimin P: Nanozymes: Gold-nanoparticle-based transphosphorylation
catalysts. Angew Chem Int Ed Engl. 43:6165–6169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei H and Wang E: Nanomaterials with
enzyme-like characteristics (nanozymes): Next-generation artificial
enzymes. Chem Soc Rev. 42:6060–6093. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mahmudunnabi RG, Farhana FZ, Kashaninejad
N, Firoz SH, Shim YB and Shiddiky MJA: Nanozyme-based
electrochemical biosensors for disease biomarker detection.
Analyst. 145:4398–4420. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Luo Q, Shao N, Zhang AC, Chen CF, Wang D,
Luo LP and Xiao ZY: Smart biomimetic nanozymes for precise
molecular imaging: Application and challenges. Pharmaceuticals
(Basel). 16:2492023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alvarado-Ramírez L, Rostro-Alanis M,
Rodríguez-Rodríguez J, Sosa-Hernández JE, Melchor-Martínez EM,
Iqbal HMN and Parra-Saldívar R: Enzyme (Single and Multiple) and
nanozyme biosensors: Recent developments and their novel
applications in the water-food-health nexus. Biosensors (Basel).
11:4102021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu J, Wang X, Wang Q, Lou Z, Li S, Zhu Y,
Qin L and Wei H: Nanomaterials with enzyme-like characteristics
(nanozymes): next-generation artificial enzymes (II). Chem Soc Rev.
48:1004–1076. 2019. View Article : Google Scholar
|
|
25
|
Jiang D, Ni D, Rosenkrans ZT, Huang P, Yan
X and Cai W: Nanozyme: new horizons for responsive biomedical
applications. Chem Soc Rev. 48:3683–3704. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang Y, Ren J and Qu X: Nanozymes:
Classification, catalytic mechanisms, activity regulation, and
applications. Chem Rev. 119:4357–4412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin Y, Ren J and Qu X: Nano-gold as
artificial enzymes: Hidden talents. Adv Mater. 26:4200–4217. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Comotti M, Della Pina C, Matarrese R and
Rossi M: The catalytic activity of 'naked' gold particles. Angew
Chem Int Ed Engl. 43:5812–5815. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Comotti M, Della Pina C, Falletta E and
Rossi M: Aerobic oxidation of glucose with gold catalyst: Hydrogen
peroxide as intermediate and reagent. Adv Synth Catal. 348:313–316.
2006. View Article : Google Scholar
|
|
30
|
Sengupta P, Pramanik K, Datta P and Sarkar
P: Chemically modified carbon nitride-chitin-acetic acid hybrid as
a metal-free bifunctional nanozyme cascade of glucose
oxidase-peroxidase for 'click off' colorimetric detection of
peroxide and glucose. Biosens Bioelectron. 154:1120722020.
View Article : Google Scholar
|
|
31
|
Zhang K, Zhuo Z, Fan G, Wang Z, Chen S, Xu
L, Wen Y and Wang P: Nano-ZnS decorated hierarchically porous
carbon electrocatalyst with multiple enzyme-like activities as a
nanozyme sensing platform for simultaneous detection of dopamine,
uric acid, guanine, and adenine. Nanoscale. 13:20078–20090. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu R, Sun M, Liu X, Qin F, Zhang X, Qian
Z, Huang J, Li Y, Tan T, Chen W and Chen Z: Oxidase-like ZnCoFe
three-atom nanozyme as a colorimetric platform for ascorbic acid
sensing. Anal Chem. 94:14308–14316. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ragg R, Natalio F, Tahir MN, Janssen H,
Kashyap A, Strand D, Strand S and Tremel W: Molybdenum trioxide
nanoparticles with intrinsic sulfite oxidase activity. ACS Nano.
8:5182–5189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mu Q, Sun Y, Guo A, Xu X, Qin B and Cai A:
A bifunctionalized NiCo2O4-Au composite: Intrinsic peroxidase and
oxidase catalytic activities for killing bacteria and disinfecting
wound. J Hazard Mater. 402:1239392021. View Article : Google Scholar
|
|
35
|
Lei L and Wang K: Synergistic combination
of an intelligent nanozyme and radiotherapy for treating renal
cancer. Int J Nanomedicine. 19:699–707. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen L, Xing S, Lei Y, Chen Q, Zou Z, Quan
K, Qing Z, Liu J and Yang R: A glucose-powered activatable nanozyme
breaking pH and H2O2 limitations for treating diabetic infections.
Angew Chem Int Ed Engl. 60:23534–23539. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao L, Zhuang J, Nie L, Zhang J, Zhang Y,
Gu N, Wang T, Feng J, Yang D, Perrett S and Yan X: Intrinsic
peroxidase-like activity of ferromagnetic nanoparticles. Nat
Nanotechnol. 2:577–583. 2007. View Article : Google Scholar
|
|
38
|
Chen J, Liu X, Zheng G, Feng W, Wang P,
Gao J, Liu J, Wang M and Wang Q: Detection of glucose based on
noble metal nanozymes: Mechanism, activity regulation, and
enantioselective recognition. Small. 19:e22059242023. View Article : Google Scholar
|
|
39
|
Li P, Feng Y, Cheng D and Wei J:
Self-template synthesis of mesoporous vanadium oxide nanospheres
with intrinsic peroxidase-like activity and high antibacterial
performance. J Colloid Interface Sci. 625:435–445. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang QY, Wan CQ, Wang YX, Shen XF and Pang
YH: Bismuth-based metal-organic framework peroxidase-mimic
nanozyme: Preparation and mechanism for colorimetric-converted
ultra-trace electrochemical sensing of chromium ion. J Hazard
Mater. 451:1311482023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu X, Huang D, Lai C, Qin L, Zeng G, Xu
P, Li B, Yi H and Zhang M: Peroxidase-like activity of smart
nanomaterials and their advanced application in colorimetric
glucose biosensors. Small. 15:e19001332019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wan K, Jiang B, Tan T, Wang H and Liang M:
Surface-mediated production of complexed •oh radicals and Fe•O
species as a mechanism for iron oxide peroxidase-like nanozymes.
Small. 18:e22043722022. View Article : Google Scholar
|
|
43
|
Yao J, Cheng Y, Zhou M, Zhao S, Lin S,
Wang X, Wu J, Li S and Wei H: ROS scavenging Mn3O4 nanozymes for in
vivo anti-inflammation. Chem Sci. 9:2927–2933. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tong L, Wu L, Zai Y, Zhang Y, Su E and Gu
N: Paper-based colorimetric glucose sensor using Prussian blue
nanoparticles as mimic peroxidase. Biosens Bioelectron.
219:1147872023. View Article : Google Scholar
|
|
45
|
Wu F, Du Y, Yang J, Shao B, Mi Z, Yao Y,
Cui Y, He F, Zhang Y and Yang P: Peroxidase-like active
nanomedicine with dual glutathione depletion property to restore
oxaliplatin chemosensitivity and promote programmed cell death. ACS
Nano. 16:3647–3663. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Guo JJ, Wang Y and Zhao M: Target-directed
functionalized ferrous phosphate-carbon dots fluorescent
nanostructures as peroxidase mimetics for cancer cell detection and
ROS-mediated therapy. Sens Actuat B-Chem. 297:1267392019.
View Article : Google Scholar
|
|
47
|
Vernekar AA, Sinha D, Srivastava S,
Paramasivam PU, D'Silva P and Mugesh G: An antioxidant nanozyme
that uncovers the cytoprotective potential of vanadia nanowires.
Nat Commun. 5:53012014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Griendling KK, Camargo LL, Rios FJ,
Alves-Lopes R, Montezano AC and Touyz RM: Oxidative stress and
hypertension. Circ Res. 128:993–1020. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Eftekharpour E and Fernyhough P: Oxidative
stress and mitochondrial dysfunction associated with peripheral
neuropathy in type 1 diabetes. Antioxid Redox Signal. 37:578–596.
2022. View Article : Google Scholar
|
|
50
|
Zhao H, Zhang R, Yan X and Fan K:
Superoxide dismutase nanozymes: An emerging star for
anti-oxidation. J Mater Chem B. 9:6939–6957. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Muzykantov VR: Targeting of superoxide
dismutase and catalase to vascular endothelium. J Control Release.
71:1–21. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zelko IN, Mariani TJ and Folz RJ:
Superoxide dismutase multigene family: A comparison of the CuZn-SOD
(SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures,
evolution, and expression. Free Radic Biol Med. 33:337–349. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Miller AF: Superoxide dismutases: Ancient
enzymes and new insights. FEBS Lett. 586:585–595. 2012. View Article : Google Scholar
|
|
54
|
Jomova K, Alomar SY, Alwasel SH,
Nepovimova E, Kuca K and Valko M: Several lines of antioxidant
defense against oxidative stress: Antioxidant enzymes,
nanomaterials with multiple enzyme-mimicking activities, and
low-molecular-weight antioxidants. Arch Toxicol. 98:1323–1367.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Chen BH and Stephen Inbaraj B: Various
physicochemical and surface properties controlling the bioactivity
of cerium oxide nanoparticles. Crit Rev Biotechnol. 38:1003–1024.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen J, Patil S, Seal S and McGinnis JF:
Rare earth nanoparticles prevent retinal degeneration induced by
intracellular peroxides. Nat Nanotechnol. 1:142–150. 2006.
View Article : Google Scholar
|
|
57
|
Celardo I, Pedersen JZ, Traversa E and
Ghibelli L: Pharmacological potential of cerium oxide
nanoparticles. Nanoscale. 3:1411–1420. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Xu C and Qu X: Cerium oxide nanoparticle:
A remarkably versatile rare earth nanomaterial for biological
applications. NPG Asia Mater. 6:e902014. View Article : Google Scholar
|
|
59
|
Dugan LL, Turetsky DM, Du C, Lobner D,
Wheeler M, Almli CR, Shen CK, Luh TY, Choi DW and Lin TS:
Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci
USA. 94:9434–9439. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ali SS, Hardt JI, Quick KL, Kim-Han JS,
Erlanger BF, Huang TT, Epstein CJ and Dugan LL: A biologically
effective fullerene (C60) derivative with superoxide dismutase
mimetic properties. Free Radic Biol Med. 37:1191–1202. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ali SS, Hardt JI and Dugan LL: SOD
activity of carboxyfullerenes predicts their neuroprotective
efficacy: A structure-activity study. Nanomedicine. 4:283–294.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Xue B, Ge M, Fan K, Huang X, Yan X, Jiang
W, Jiang B and Yang Z: Mitochondria-targeted nanozymes eliminate
oxidative damage in retinal neovascularization disease. J Control
Release. 350:271–283. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Song C, Sheng L and Zhang X: Preparation
and characterization of a thermostable enzyme (Mn-SOD) immobilized
on supermagnetic nanoparticles. Appl Microbiol Biotechnol.
96:123–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Korschelt K, Ragg R, Metzger CS, Kluenker
M, Oster M, Barton B, Panthöfer M, Strand D, Kolb U, Mondeshki M,
et al: Glycine-functionalized copper(ii) hydroxide nanoparticles
with high intrinsic superoxide dismutase activity. Nanoscale.
9:3952–3960. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Kajita M, Hikosaka K, Iitsuka M, Kanayama
A, Toshima N and Miyamoto Y: Platinum nanoparticle is a useful
scavenger of superoxide anion and hydrogen peroxide. Free Radic
Res. 41:615–626. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Li Z, Zhao Y, Huang H, Zhang C, Liu H,
Wang Z, Yi M, Xie N, Shen Y, Ren X, et al: A Nanozyme-immobilized
hydrogel with endogenous ROS-scavenging and oxygen generation
abilities for significantly promoting oxidative diabetic wound
healing. Adv Healthc Mater. 11:e22015242022. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Lin A, Sun Z, Xu X, Zhao S, Li J, Sun H,
Wang Q, Jiang Q, Wei H and Shi D: Self-cascade uricase/catalase
mimics alleviate acute gout. Nano Lett. 22:508–516. 2022.
View Article : Google Scholar
|
|
68
|
Cai G, Li R, Chai X, Cai X, Zheng K, Wang
Y, Fan K, Guo Z, Guo J and Jiang W: Catalase-templated
nanozyme-loaded microneedles integrated with polymyxin B for
immunoregulation and antibacterial activity in diabetic wounds. J
Colloid Interface Sci. 667:529–542. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang C, Li Y, Yang W, Zhou L and Wei S:
Nanozyme with robust catalase activity by multiple mechanisms and
its application for hypoxic tumor treatment. Adv Healthc Mater.
10:e21006012021. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Xu D, Wu L, Yao H and Zhao L:
Catalase-like nanozymes: classification, catalytic mechanisms, and
their applications. Small. 18:e22034002022. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Fan C, Tang Y, Wang H, Huang Y, Xu F, Yang
Y, Huang Y, Rong W and Lin Y: ZIF-90 with biomimetic Zn-N
coordination structures as an effective nanozyme to mimic natural
hydrolase. Nanoscale. 14:7985–7990. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sun S, Zhang Z, Xiang Y, Cao M and Yu D:
Amino acid-mediated synthesis of the ZIF-8 nanozyme that reproduces
both the zinc-coordinated active center and hydrophobic pocket of
natural carbonic anhydrase. Langmuir. 38:1621–1630. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhou Q, Zhang T, Jie J, Hou Y, Hu Z, Jiao
Z and Su H: TiO2 as a nanozyme mimicking photolyase to repair DNA
damage. J Phys Chem Lett. 13:10929–10935. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
O'Hara AM and Shanahan F: The gut flora as
a forgotten organ. EMBO Rep. 7:688–693. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wang Y, Shen J, Handschuh-Wang S, Qiu M,
Du S and Wang B: Microrobots for targeted delivery and therapy in
digestive system. ACS Nano. 17:27–50. 2023. View Article : Google Scholar
|
|
76
|
Janowitz HD: Digestive system. Annu Rev
Physiol. 23:153–182. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Feng K, Wang G, Wang S, Ma J, Wu H, Ma M
and Zhang Y: Breaking the pH limitation of nanozymes: Mechanisms,
methods, and applications. Adv Mater. 36:e24016192024. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Hua S, Dong X, Peng Q, Zhang K, Zhang X
and Yang J: Single-atom nanozymes shines diagnostics of
gastrointestinal diseases. J Nanobiotechnology. 22:2862024.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Kelly RJ: Emerging multimodality
approaches to treat localized esophageal cancer. J Natl Compr Canc
Netw. 17:1009–1014. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Barker HE, Paget JT, Khan AA and
Harrington KJ: The tumour microenvironment after radiotherapy:
Mechanisms of resistance and recurrence. Nat Rev Cancer.
15:409–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie
MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al: Association
of reactive oxygen species levels and radioresistance in cancer
stem cells. Nature. 458:780–783. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Xie J, Gong L, Zhu S, Yong Y, Gu Z and
Zhao Y: Emerging strategies of nanomaterial-mediated tumor
radiosensitization. Adv Mater. 31:e18022442019. View Article : Google Scholar
|
|
83
|
Petroni G, Cantley LC, Santambrogio L,
Formenti SC and Galluzzi L: Radiotherapy as a tool to elicit
clinically actionable signalling pathways in cancer. Nat Rev Clin
Oncol. 19:114–131. 2022. View Article : Google Scholar :
|
|
84
|
Worrell SG, Goodman KA, Altorki NK, Ashman
JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL,
Hong TS, et al: The society of thoracic surgeons/american society
for radiation oncology updated clinical practice guidelines on
multimodality therapy for locally advanced cancer of the esophagus
or gastroesophageal junction. Ann Thorac Surg. 117:15–32. 2024.
View Article : Google Scholar
|
|
85
|
Zhou LL, Guan Q, Zhou W, Kan JL, Teng K,
Hu M and Dong YB: A multifunctional covalent organic framework
nanozyme for promoting ferroptotic radiotherapy against esophageal
cancer. ACS Nano. 17:20445–20461. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Zhou X, You M, Wang F, Wang Z, Gao X, Jing
C, Liu J, Guo M, Li J, Luo A, et al: Multifunctional
graphdiyne-cerium oxide nanozymes facilitate MicroRNA delivery and
attenuate tumor hypoxia for highly efficient radiotherapy of
esophageal cancer. Adv Mater. 33:e21005562021. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Liu J, Gao J, Zhang A, Guo Y, Fan S, He Y,
Yang K, Wang J, Cui D and Cheng Y: Carbon nanocage-based nanozyme
as an endogenous H2O2-activated oxygenerator for real-time bimodal
imaging and enhanced phototherapy of esophageal cancer. Nanoscale.
12:21674–21686. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wu Y, Song M, Xin Z, Zhang X, Zhang Y,
Wang C, Li S and Gu N: Ultra-small particles of iron oxide as
peroxidase for immunohistochemical detection. Nanotechnology.
22:2257032011. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Wang P, Wang T, Hong J, Yan X and Liang M:
Nanozymes: A new disease imaging strategy. Front Bioeng Biotechnol.
8:152020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Krause J, Brokmann F, Rosenbaum C and
Weitschies W: The challenges of drug delivery to the esophagus and
how to overcome them. Expert Opin Drug Deliv. 19:119–131. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Senchukova MA: Helicobacter pylori and
gastric cancer progression. Curr Microbiol. 79:3832022. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Marshall BJ and Warren JR: Unidentified
curved bacilli in the stomach of patients with gastritis and peptic
ulceration. Lancet. 1:1311–1315. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Ansari S and Yamaoka Y: Helicobacter
pylori infection, its laboratory diagnosis, and antimicrobial
resistance: A perspective of clinical relevance. Clin Microbiol
Rev. 35:e00258212022. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Hu Y, Zhu Y and Lu NH: The management of
Helicobacter pylori infection and prevention and control of gastric
cancer in China. Front Cell Infect Microbiol. 12:10492792022.
View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Zhang L, Zhang L, Deng H, Li H, Tang W,
Guan L, Qiu Y, Donovan MJ, Chen Z and Tan W: In vivo activation of
pH-responsive oxidase-like graphitic nanozymes for selective
killing of Helicobacter pylori. Nat Commun. 12:20022021. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Efentakis M and Dressman JB: Gastric juice
as a dissolution medium: Surface tension and pH. Eur J Drug Metab
Pharmacokinet. 23:97–102. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Yan LX, Wang BB, Zhao X, Chen LJ and Yan
XP: A pH-Responsive persistent luminescence nanozyme for selective
imaging and killing of helicobacter pylori and common resistant
bacteria. ACS Appl Mater Interfaces. 13:60955–60965. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Guo Z, Zhu AT, Fang RH and Zhang L: Recent
developments in nanoparticle-based photo-immunotherapy for cancer
treatment. Small Methods. 7:e23002522023. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Zhang A, Pan S, Zhang Y, Chang J, Cheng J,
Huang Z, Li T, Zhang C, de la Fuentea JM, Zhang Q and Cui D:
Carbon-gold hybrid nanoprobes for real-time imaging,
photothermal/photodynamic and nanozyme oxidative therapy.
Theranostics. 9:3443–3458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Zhang Y, Li Y, Li J, Mu F, Wang J, Shen C,
Wang H, Huang F, Chen B, Luo Z and Wang L: DNA-Templated Ag@ Pd
nanoclusters for NIR-II photoacoustic imaging-guided
photothermal-augmented nanocatalytic therapy. Adv Healthc Mater.
12:e23002672023. View Article : Google Scholar
|
|
101
|
Ma J, Yao Q, Lv S, Yi J, Zhu D, Zhu C,
Wang L and Su S: Integrated triple signal amplification strategy
for ultrasensitive electrochemical detection of gastric
cancer-related microRNA utilizing MoS2-based nanozyme,
hybridization chain reaction, and horseradish peroxidase. J
Nanobiotechnology. 22:5962024. View Article : Google Scholar :
|
|
102
|
Yao QH, Zeng MH, Zhang C, Zheng F, Jin JW,
Ye TX, Wang YT, Chen XM, Guo ZY and Chen X: Polyphenol briged
bimetallic-heterostructure inducing chiral peroxidase nanozyme
activity for enantiomers identification in gastric cancer. Biosens
Bioelectron. 282:1174492025. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Zhuang Y, Yin H, Huang Y, Jiang F, Li L,
Wu Z, Yang Y, Cao X and Wei W: Catalytic hairpin assembly-powered
nanozyme-SERS dual-function sensing system for ultrasensitive
detection of gastric precancerous lesions. Biosens Bioelectron.
283:1175362025. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Deng X, Wu J, Jiang ZW, Liu W, Gong X, Cao
Y, Zhang P and Wang Y: Detection of d-Amino acids in saliva for
gastric cancer diagnosis using Pt/MXene plasmonic nanozymes. Anal
Chem. 97:10289–10298. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Asrani SK, Devarbhavi H, Eaton J and
Kamath PS: Burden of liver diseases in the world. J Hepatol.
70:151–171. 2019. View Article : Google Scholar
|
|
106
|
Hassan A and Fontana RJ: The diagnosis and
management of idiosyncratic drug-induced liver injury. Liver Int.
39:31–41. 2019. View Article : Google Scholar
|
|
107
|
Coccolini F, Coimbra R, Ordonez C, Kluger
Y, Vega F, Moore EE, Biffl W, Peitzman A, Horer T, Abu-Zidan FM, et
al: Liver trauma: WSES 2020 guidelines. World J Emerg Surg.
15:242020. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Yan M, Huo Y, Yin S and Hu H: Mechanisms
of acetaminophen-induced liver injury and its implications for
therapeutic interventions. Redox Biol. 17:274–283. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Zhou C, Zhang L, Xu Z, Sun T, Gong M, Liu
Y and Zhang D: Self-propelled ultrasmall AuNPs-tannic acid hybrid
nanozyme with ROS-scavenging and anti-inflammatory activity for
drug-induced liver injury alleviation. Small. 19:e22064082023.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Bai H, Kong F, Feng K, Zhang X, Dong H,
Liu D, Ma M, Liu F, Gu N and Zhang Y: Prussian blue nanozymes
prevent anthracycline-induced liver injury by attenuating oxidative
stress and regulating inflammation. ACS Appl Mater Interfaces.
13:42382–42395. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Xia F, Hu X, Zhang B, Wang X, Guan Y, Lin
P, Ma Z, Sheng J, Ling D and Li F: Ultrasmall ruthenium
nanoparticles with boosted antioxidant activity upregulate
regulatory T cells for highly efficient liver injury therapy.
Small. 18:e22015582022. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Wu H, Xia F, Zhang L, Fang C, Lee J, Gong
L, Gao J, Ling D and Li F: A ROS-Sensitive nanozyme-augmented
photoacoustic nanoprobe for early diagnosis and therapy of acute
liver failure. Adv Mater. 34:e21083482022. View Article : Google Scholar
|
|
113
|
Marroni CA, Fleck AM Jr, Fernandes SA,
Galant LH, Mucenic M, de Mattos Meine MH, Mariante-Neto G and
Brandão ABM: Liver transplantation and alcoholic liver disease:
History, controversies, and considerations. World J Gastroenterol.
24:2785–2805. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Geng X, Du X, Wang W, Zhang C, Liu X, Qu
Y, Zhao M, Li W, Zhang M, Tu K and Li YQ: Confined cascade
metabolic reprogramming nanoreactor for targeted alcohol
detoxification and alcoholic liver injury management. ACS Nano.
17:7443–7455. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Friedman SL and Pinzani M: Hepatic
fibrosis 2022: Unmet needs and a blueprint for the future.
Hepatology. 75:473–488. 2022. View Article : Google Scholar
|
|
116
|
Zhang M, Serna-Salas S, Damba T, Borghesan
M, Demaria M and Moshage H: Hepatic stellate cell senescence in
liver fibrosis: Characteristics, mechanisms and perspectives. Mech
Ageing Dev. 199:1115722021. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Carloni V, Luong TV and Rombouts K:
Hepatic stellate cells and extracellular matrix in hepatocellular
carcinoma: More complicated than ever. Liver Int. 34:834–843. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Ezhilarasan D, Sokal E and Najimi M:
Hepatic fibrosis: It is time to go with hepatic stellate
cell-specific therapeutic targets. Hepatobiliary Pancreat Dis Int.
17:192–197. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Zhang X, Zhang S, Yang Z, Wang Z, Tian X
and Zhou R: Self-cascade MoS(2) nanozymes for efficient
intracellular antioxidation and hepatic fibrosis therapy.
Nanoscale. 13:12613–12622. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Lu Q, Zhou Y, Xu M, Liang X, Jing H, Wang
X and Li N: Sequential delivery for hepatic fibrosis treatment
based on carvedilol loaded star-like nanozyme. J Control Release.
341:247–260. 2022. View Article : Google Scholar
|
|
121
|
Tang Z, Liu Y, He M and Bu W: Chemodynamic
therapy: Tumour microenvironment-mediated fenton and fenton-like
reactions. Angew Chem Int Ed Engl. 58:946–956. 2019. View Article : Google Scholar
|
|
122
|
Tarangelo A and Dixon SJ: Nanomedicine: An
iron age for cancer therapy. Nat Nanotechnol. 11:921–922. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Jiang Y, Zhao X, Huang J, Li J, Upputuri
PK, Sun H, Han X, Pramanik M, Miao Y, Duan H, et al: Transformable
hybrid semiconducting polymer nanozyme for second near-infrared
photothermal ferrotherapy. Nat Commun. 11:18572020. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Dong C, Dai X, Wang X, Lu Q, Chen L, Song
X, Ding L, Huang H, Feng W, Chen Y and Chang M: A Calcium fluoride
nanozyme for ultrasound-amplified and Ca2+ -overload-enhanced
catalytic tumor nanotherapy. Adv Mater. 34:e22056802022. View Article : Google Scholar
|
|
125
|
Kang S, Gil Y, Yim G, Min D and Jang H:
Osmium-tellurium nanozymes for pentamodal combinatorial cancer
therapy. ACS Appl Mater Interfaces. 13:44124–44135. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Jiang B, Yan L, Zhang J, Zhou M, Shi G,
Tian X, Fan K, Hao C and Yan X: Biomineralization synthesis of the
cobalt nanozyme in SP94-ferritin nanocages for prognostic diagnosis
of hepatocellular carcinoma. ACS Appl Mater Interfaces.
11:9747–9755. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Liu X, Mei X, Yang J and Li Y:
Hydrogel-involved colorimetric platforms based on layered double
oxide nanozymes for point-of-care detection of liver-related
biomarkers. ACS Appl Mater Interfaces. 14:6985–6993. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
128
|
He C, Ke Z, Liu K, Peng J, Yang Q, Wang L,
Feng G and Fang J: Nanozyme-based dual-signal sensing system for
colorimetric and photothermal detection of AChE activity in the
blood of liver-injured mice. Anal Bioanal Chem. 415:2655–2664.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Liu J, Shi X, Qu Y and Wang G:
Functionalized ZnMnFe2O4-PEG-FA nanoenzymes integrating diagnosis
and therapy for targeting hepatic carcinoma guided by
multi-modality imaging. Nanoscale. 15:11013–11025. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Alimardani V, Rahiminezhad Z, DehghanKhold
M, Farahavar G, Jafari M, Abedi M, Moradi L, Niroumand U, Ashfaq M,
Abolmaali SS and Yousefi G: Nanotechnology-based cell-mediated
delivery systems for cancer therapy and diagnosis. Drug Deliv
Transl Res. 13:189–221. 2023. View Article : Google Scholar
|
|
131
|
Mederos MA, Reber HA and Girgis MD: Acute
pancreatitis: A review. JAMA. 325:382–390. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Tan JH, Cao RC, Zhou L, Zhou ZT, Chen HJ,
Xu J, Chen XM, Jin YC, Lin JY, Zeng JL, et al: ATF6 aggravates
acinar cell apoptosis and injury by regulating p53/AIFM2
transcription in severe acute pancreatitis. Theranostics.
10:8298–8314. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Sah RP, Garg P and Saluja AK: Pathogenic
mechanisms of acute pancreatitis. Curr Opin Gastroenterol.
28:507–515. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Bhatia M, Wong FL, Cao Y, Lau HY, Huang J,
Puneet P and Chevali L: Pathophysiology of acute pancreatitis.
Pancreatology. 5:132–144. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Escobar J, Pereda J, López-Rodas G and
Sastre J: Redox signaling and histone acetylation in acute
pancreatitis. Free Radic Biol Med. 52:819–837. 2012. View Article : Google Scholar
|
|
136
|
Pasari LP, Khurana A, Anchi P, Aslam Saifi
M, Annaldas S and Godugu C: Visnagin attenuates acute pancreatitis
via Nrf2/NFκB pathway and abrogates associated multiple organ
dysfunction. Biomed Pharmacother. 112:1086292019. View Article : Google Scholar
|
|
137
|
Pérez S, Pereda J, Sabater L and Sastre J:
Redox signaling in acute pancreatitis. Redox Biol. 5:1–14. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Yao Q, Jiang X, Zhai YY, Luo LZ, Xu HL,
Xiao J, Kou L and Zhao YZ: Protective effects and mechanisms of
bilirubin nanomedicine against acute pancreatitis. J Control
Release. 322:312–325. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Jakkampudi A, Jangala R, Reddy BR, Mitnala
S, Nageshwar Reddy D and Talukdar R: NF-κB in acute pancreatitis:
Mechanisms and therapeutic potential. Pancreatology. 16:477–488.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Rakonczay Z Jr, Hegyi P, Takács T,
McCarroll J and Saluja AK: The role of NF-kappaB activation in the
pathogenesis of acute pancreatitis. Gut. 57:259–267. 2008.
View Article : Google Scholar
|
|
141
|
Xie X, Zhao J, Gao W, Chen J, Hu B, Cai X
and Zheng Y: Prussian blue nanozyme-mediated nanoscavenger
ameliorates acute pancreatitis via inhibiting TLRs/NF-κB signaling
pathway. Theranostics. 11:3213–3228. 2021. View Article : Google Scholar :
|
|
142
|
Yang L, Ye F, Liu J, Klionsky DJ, Tang D
and Kang R: Extracellular SQSTM1 exacerbates acute pancreatitis by
activating autophagy-dependent ferroptosis. Autophagy.
19:1733–1744. 2023. View Article : Google Scholar :
|
|
143
|
Li H, Lin Y, Zhang L, Zhao J and Li P:
Ferroptosis and its emerging roles in acute pancreatitis. Chin Med
J (Engl). 135:2026–2034. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Fan R, Sui J, Dong X, Jing B and Gao Z:
Wedelolactone alleviates acute pancreatitis and associated lung
injury via GPX4 mediated suppression of pyroptosis and ferroptosis.
Free Radic Biol Med. 173:29–40. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Li Y, Cai R, Chen K, Zhang Y, Chen X, Sun
B, Jiang Y, Tan C, Peng C, Song Y, et al: Ca/Fe-Based nanozymes
relieve severe acute pancreatitis by ferroptosis regulation and
reactive oxygen species scavenging. ACS Appl. Nano Mater.
14:12968–12979. 2023. View Article : Google Scholar
|
|
146
|
Xie P, Zhang L, Shen H, Wu H, Zhao J, Wang
S and Hu L: Biodegradable MoSe2-polyvinylpyrrolidone nanoparticles
with multi-enzyme activity for ameliorating acute pancreatitis. J
Nanobiotechnology. 20:1132022. View Article : Google Scholar :
|
|
147
|
Sarvepalli D, Rashid MU, Rahman AU, Ullah
W, Hussain I, Hasan B, Jehanzeb S, Khan AK, Jain AG, Khetpal N and
Ahmad S: Gemcitabine: A review of chemoresistance in pancreatic
cancer. Crit Rev Oncog. 24:199–212. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Kang S, Gil YG, Min DH and Jang H:
Nonrecurring circuit nanozymatic enhancement of hypoxic pancreatic
cancer phototherapy using speckled Ru-Te hollow nanorods. ACS Nano.
14:4383–4394. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Chen H, Qiu Y, Ding D, Lin H, Sun W, Wang
GD, Huang W, Zhang W, Lee D, Liu G, et al: Gadolinium-encapsulated
graphene carbon nanotheranostics for imaging-guided photodynamic
therapy. Adv Mater. Jul 23–2018.Epub ahead of print. View Article : Google Scholar
|
|
150
|
Li S, Shang L, Xu B, Wang S, Gu K, Wu Q,
Sun Y, Zhang Q, Yang H, Zhang F, et al: A nanozyme with
photo-enhanced dual enzyme-like activities for deep pancreatic
cancer therapy. Angew Chem Int Ed Engl. 58:12624–12631. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Chen J, Bao Y, Song Y, Zhang C, Qiu F, Sun
Y, Xin L, Cao J, Jiang Y, Luo J, et al: Hypoxia-alleviated
nanoplatform to enhance chemosensitivity and sonodynamic effect in
pancreatic cancer. Cancer Lett. 520:100–108. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Zhang G, Li N, Qi Y, Zhao Q, Zhan J and Yu
D: Synergistic ferroptosis-gemcitabine chemotherapy of the
gemcitabine loaded carbonaceous nanozymes to enhance the treatment
and magnetic resonance imaging monitoring of pancreatic cancer.
Acta Biomater. 142:284–297. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Ramos GP and Papadakis KA: Mechanisms of
disease: Inflammatory bowel diseases. Mayo Clin Proc. 94:155–165.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Xavier RJ and Podolsky DK: Unravelling the
pathogenesis of inflammatory bowel disease. Nature. 448:427–434.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Liu P, Li Y, Wang R, Ren F and Wang X:
Oxidative stress and antioxidant nanotherapeutic approaches for
inflammatory bowel disease. Biomedicines. 10:852021. View Article : Google Scholar
|
|
156
|
Weiss GA and Hennet T: Mechanisms and
consequences of intestinal dysbiosis. Cell Mol Life Sci.
74:2959–2977. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
157
|
Eliakim R and Magro F: Imaging techniques
in IBD and their role in follow-up and surveillance. Nat Rev
Gastroenterol Hepatol. 11:722–736. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Cao Y, Cheng K, Yang M, Deng Z, Ma Y, Yan
X, Zhang Y, Jia Z, Wang J, Tu K, et al: Orally administration of
cerium oxide nanozyme for computed tomography imaging and
anti-inflammatory/anti-fibrotic therapy of inflammatory bowel
disease. J Nanobiotechnology. 21:212023. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Li X, Cao L, Li J, Li Z, Ma H, Cheng S, Xu
H and Zhao Y: Orally Administrated Inulin-Modified Nanozymes for
CT-Guided IBD Theranostics. Int J Nanomedicine. 20:2119–2131. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
160
|
He Y, Jin Z, Wang Y, Wu C, He X, Weng W,
Cai X and Cheng K: Multifunctional double-loaded oral nanoplatform
for computed tomography imaging-guided and integrated treatment of
inflammatory bowel disease. ACS Nano. 19:14893–14913. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
Deng Z, Ma W, Ding C, Wei C, Gao B, Zhu M,
Zhang Y, Wu F and Zhang M, Li R and Zhang M: Metal polyphenol
network/cerium oxide artificial enzymes therapeutic nanoplatform
for MRI/CT-aided intestinal inflammation management. Nano Today.
53:1020442023. View Article : Google Scholar
|
|
162
|
Zhou D, Yin Y, Zhu Z, Gao Y, Yang J, Pan Y
and Song Y: Orally administered platinum nanomarkers for urinary
monitoring of inflammatory bowel disease. ACS Nano. 16:18503–18514.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Duan ZY, Liu JQ, Yin P, Li JJ, Cai GY and
Chen XM: Impact of aging on the risk of platinum-related renal
toxicity: A systematic review and meta-analysis. Cancer Treat Rev.
69:243–253. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Ma Y, Zhao J, Cheng L, Li C, Yan X, Deng
Z, Zhang Y, Liang J, Liu C and Zhang M: Versatile carbon dots with
superoxide dismutase-like nanozyme activity and red fluorescence
for inflammatory bowel disease therapeutics. Carbon. 204:526–537.
2023. View Article : Google Scholar
|
|
165
|
Zhao S, Li Y, Liu Q, Li S, Cheng Y, Cheng
C, Sun Z, Du Y, Butch CJ and Wei H: An Orally Administered
CeO2@montmorillonite nanozyme targets inflammation for inflammatory
bowel disease therapy. Adv Funct Mater. 30:20046922020. View Article : Google Scholar
|
|
166
|
Wang Q, Cheng C, Zhao S, Liu Q, Zhang Y,
Liu W, Zhao X, Zhang H, Pu J, Zhang S, et al: A valence-engineered
self-cascading antioxidant nanozyme for the therapy of inflammatory
bowel disease. Angew Chem Int Ed Engl. 61:e2022011012022.
View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Liu Y, Cheng Y, Zhang H, Zhou M, Yu Y, Lin
S, Jiang B, Zhao X, Miao L, Wei CW, et al: Integrated cascade
nanozyme catalyzes in vivo ROS scavenging for anti-inflammatory
therapy. Sci Adv. 6:eabb26952020. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
Yu Y, Zhao X, Xu X, Cai C, Tang X, Zhang
Q, Zhong L, Zhou F, Yang D and Zhu Z: Rational design of orally
administered cascade nanozyme for inflammatory bowel disease
therapy. Adv Mater. 35:e23049672023. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Huang Q, Yang Y, Zhu Y, Chen Q, Zhao T,
Xiao Z, Wang M, Song X, Jiang Y, Yang Y, et al: Oral metal-free
melanin nanozymes for natural and durable targeted treatment of
inflammatory bowel disease (IBD). Small. 19:e22073502023.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Yao H, Wang F, Chong H, Wang J, Bai Y, Du
M, Yuan X, Yang X, Wu M, Li Y and Pang H: A Curcumin-modified
coordination polymers with ros scavenging and macrophage phenotype
regulating properties for efficient ulcerative colitis treatment.
Adv Sci (Weinh). 10:e23006012023. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Cao F, Jin L, Gao Y, Ding Y, Wen H, Qian
Z, Zhang C, Hong L, Yang H, Zhang J, et al:
Artificial-enzymes-armed Bifidobacterium longum probiotics for
alleviating intestinal inflammation and microbiota dysbiosis. Nat
Nanotechnol. 18:617–627. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Zhu H and Li YR: Oxidative stress and
redox signaling mechanisms of inflammatory bowel disease: Updated
experimental and clinical evidence. Exp Biol Med (Maywood).
237:474–480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Miao Z, Jiang S, Ding M, Sun S, Ma Y,
Younis MR, He G, Wang J, Lin J, Cao Z, et al: Ultrasmall rhodium
nanozyme with RONS scavenging and photothermal activities for
anti-inflammation and antitumor theranostics of colon diseases.
Nano Lett. 20:3079–3089. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Wang Y, Dai X, Wu L, Xiang H, Chen Y and
Zhang R: Atomic vacancies-engineered ultrathin trimetallic nanozyme
with anti-inflammation and antitumor performances for intestinal
disease treatment. Biomaterials. 299:1221782023. View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Chen J, Xu F, Ruan X, Sun J, Zhang Y,
Zhang H, Zhao J, Zheng J, Larsson SC, Wang X, et al: Therapeutic
targets for inflammatory bowel disease: Proteome-wide Mendelian
randomization and colocalization analyses. EBioMedicine.
89:1044942023. View Article : Google Scholar : PubMed/NCBI
|
|
176
|
Gonzalez CG, Mills RH, Zhu Q, Sauceda C,
Knight R, Dulai PS and Gonzalez DJ: Location-specific signatures of
Crohn's disease at a multi-omics scale. Microbiome. 10:1332022.
View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Bagherzadeh F and Mohammadi-Moghadam F:
New insights into the role of metal(loid)s in the development of
ulcerative colitis: A systematic review. Environ Sci Pollut Res
Int. 30:66486–66493. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Chen X, Wang S, Mao X, Xiang X, Ye S, Chen
J, Zhu A, Meng Y, Yang X, Peng S, et al: Adverse health effects of
emerging contaminants on inflammatory bowel disease. Front Public
Health. 11:11407862023. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Li M, Liu J, Shi L, Zhou C, Zou M, Fu D,
Yuan Y, Yao C, Zhang L, Qin S, et al: Gold nanoparticles-embedded
ceria with enhanced antioxidant activities for treating
inflammatory bowel disease. Bioact Mater. 25:95–106.
2023.PubMed/NCBI
|
|
180
|
Kim HS, Lee S and Lee DY: Aurozyme: A
revolutionary nanozyme in colitis, switching peroxidase-like to
catalase-like activity. Small. 19:e23023312023. View Article : Google Scholar : PubMed/NCBI
|
|
181
|
Zhao H, Du Y, Liu L, Du Y, Cui K, Yu P, Li
L, Zhu Y, Jiang W, Li Z, et al: Oral nanozyme-engineered probiotics
for the treatment of ulcerative colitis. J Mater Chem B.
10:4002–4011. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Chen QW, Cao MW, Qiao JY, Li QR and Zhang
XZ: Integrated cascade catalysis of microalgal bioenzyme and
inorganic nanozyme for anti-inflammation therapy. Nanoscale Horiz.
8:489–498. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
183
|
Salas A, Hernandez-Rocha C, Duijvestein M,
Faubion W, McGovern D, Vermeire S, Vetrano S and Vande Casteele N:
JAK-STAT pathway targeting for the treatment of inflammatory bowel
disease. Nat Rev Gastroenterol Hepatol. 17:323–337. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Wang B and Shen J: NF-κB inducing kinase
regulates intestinal immunity and homeostasis. Front Immunol.
13:8956362022. View Article : Google Scholar
|
|
185
|
Zhu D, Wu H, Jiang K, Xu Y, Miao Z, Wang H
and Ma Y: Zero-valence selenium-enriched prussian blue nanozymes
reconstruct intestinal barrier against inflammatory bowel disease
via inhibiting ferroptosis and T cells differentiation. Adv Healthc
Mater. 12:e22031602023. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Wang CJ, Ko GR, Lee YY, Park J, Park W,
Park TE, Jin Y, Kim SN, Lee JS and Park CG: Polymeric DNase-I
nanozymes targeting neutrophil extracellular traps for the
treatment of bowel inflammation. Nano Converg. 11:62024. View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Ma Y, Gao W, Zhang Y, Yang M, Yan X, Zhang
Y, Li G, Liu C, Xu C and Zhang M: Biomimetic MOF nanoparticles
delivery of C-Dot nanozyme and CRISPR/Cas9 system for site-specific
treatment of ulcerative colitis. ACS Appl Mater Interfaces.
14:6358–6369. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Stoffel EM and Murphy CC: Epidemiology and
mechanisms of the increasing incidence of colon and rectal cancers
in young adults. Gastroenterology. 158:341–353. 2020. View Article : Google Scholar
|
|
189
|
Clarke WT and Feuerstein JD: Colorectal
cancer surveillance in inflammatory bowel disease: Practice
guidelines and recent developments. World J Gastroenterol.
25:4148–4157. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Hou YJ, Yang XX, Liu RQ, Zhao D, Guo CX,
Zhu AC, Wen MN, Liu Z, Qu GF and Meng HX: Pathological mechanism of
photodynamic therapy and photothermal therapy based on
nanoparticles. Int J Nanomedicine. 15:6827–6838. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
191
|
Zhu X, Gong Y, Liu Y, Yang C, Wu S, Yuan
G, Guo X, Liu J and Qin X: Ru@CeO2 yolk shell nanozymes: Oxygen
supply in situ enhanced dual chemotherapy combined with
photothermal therapy for orthotopic/subcutaneous colorectal cancer.
Biomaterials. 242:1199232020. View Article : Google Scholar
|
|
192
|
Zhou R, Ohulchanskyy TY, Xu Y, Ziniuk R,
Xu H, Liu L and Qu J: Tumor-microenvironment-activated NIR-II
nanotheranostic platform for precise diagnosis and treatment of
colon cancer. ACS Appl Mater Interfaces. 14:23206–23218. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Agostinis P, Berg K, Cengel KA, Foster TH,
Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel
D, et al: Photodynamic therapy of cancer: An update. CA Cancer J
Clin. 61:250–281. 2011.PubMed/NCBI
|
|
194
|
Hao Y, Chen Y, He X, Yu Y, Han R, Li Y,
Yang C, Hu D and Qian Z: Polymeric nanoparticles with
ROS-responsive prodrug and platinum nanozyme for enhanced
chemophotodynamic therapy of colon cancer. Adv Sci (Weinh).
7:20018532020. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Duo Y, Suo M, Zhu D, Li Z, Zheng Z and
Tang BZ: AIEgen-based bionic nanozymes for the interventional
photodynamic therapy-based treatment of orthotopic colon cancer.
ACS Appl Mater Interfaces. 14:26394–26403. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Son S, Kim JH, Wang X, Zhang C, Yoon SA,
Shin J, Sharma A, Lee MH, Cheng L, Wu J and Kim JS: Multifunctional
sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev.
49:3244–3261. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
197
|
Zhang Y, Zhao J, Zhang L, Zhao Y, Zhang Y,
Cheng L, Wang D, Liu C and Zhang M, Fan K and Zhang M: A cascade
nanoreactor for enhancing sonodynamic therapy on colorectal cancer
via synergistic ROS augment and autophagy blockage. Nano Today.
49:1017982023. View Article : Google Scholar
|
|
198
|
Wang G, He X and Wang Q: Intratumoral
bacteria are an important 'accomplice' in tumor development and
metastasis. Biochim Biophys Acta Rev Cancer. 1878:1888462023.
View Article : Google Scholar
|
|
199
|
Wang X, Chen Q, Zhu Y, Wang K, Chang Y, Wu
X, Bao W, Cao T, Chen H, Zhang Y and Qin H: Destroying
pathogen-tumor symbionts synergizing with catalytic therapy of
colorectal cancer by biomimetic protein-supported single-atom
nanozyme. Signal Transduct Target Ther. 8:2772023. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Cao F, Jin L, Zhang C, Gao Y, Qian Z, Wen
H, Yang S, Ye Z, Hong L, Yang H, et al: engineering clinically
relevant probiotics with switchable 'nano-promoter' and
'nano-effector' for precision tumor therapy. Adv Mater.
36:e23042572023. View Article : Google Scholar
|
|
201
|
Cabrero-Martín A, Santiago S, Serafín V,
Pedrero M, Montero-Calle A, Pingarrón JM, Barderas R and Campuzano
S: Multifunctional cerium nanolabels in electrochemical
immunosensing with improved robustness and performance:
Determination of TIM-1 in colorectal cancer scenarios as a case
study. Mikrochim Acta. 192:2432025. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Liu X, Fang Y, Liu J, Chen X, Teng F and
Li C: Nanozyme-based pump-free microfluidic chip for colorectal
cancer diagnosis via circulating cancer stem cell detection. ACS
Sens. 9:5090–5098. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
203
|
Bhattacharjee R, Tanaka S, Moriam S, Masud
MK, Lin J, Alshehri SM, Ahamad T, Salunkhe RR, Nguyen NT, Yamauchi
Y, et al: Porous nanozymes: The peroxidase-mimetic activity of
mesoporous iron oxide for the colorimetric and electrochemical
detection of global DNA methylation. J Mater Chem B. 6:4783–4791.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Lee MS, Menter DG and Kopetz S: Right
versus left colon cancer biology: Integrating the consensus
molecular subtypes. J Natl Compr Canc Netw. 15:411–419. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Marisa L, de Reyniès A, Duval A, Selves J,
Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D,
Ayadi M, et al: Gene expression classification of colon cancer into
molecular subtypes: Characterization, validation, and prognostic
value. PLoS Med. 10:e10014532013. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Hao Y, Liu T, Zhou H, Xu R, Li K, Chen M
and Chen Y: Oxygen-supplying ROS-responsive prodrug for synergistic
chemotherapy and photodynamic therapy of colon cancer. Front
Pharmacol. 15:13255442024. View Article : Google Scholar : PubMed/NCBI
|
|
207
|
Kim S, Sundaram A, Mathew AP, Hareshkumar
VS, Mohapatra A, Thomas RG, Bui TTM, Moon K, Kweon S, Park IK and
Jeong YY: In situ hypoxia modulating nano-catalase for amplifying
DNA damage in radiation resistive colon tumors. Biomater Sci.
11:6177–6192. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Sun L, Gao W, Liu J, Wang J, Li L, Yu H
and Xu ZP: O2-supplying nanozymes alleviate hypoxia and deplete
lactate to eliminate tumors and activate antitumor immunity. ACS
Appl Mater Interfaces. 14:56644–56657. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Zhang C, Chen L, Bai Q, Wang L, Li S, Sui
N, Yang D and Zhu Z: Nonmetal graphdiyne nanozyme-based
ferroptosis-apoptosis strategy for colon cancer therapy. ACS Appl
Mater Interfaces. 14:27720–27732. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
210
|
Du J, Liu J, Zhao Z, Dai J, Li K and Lin
Y: Nonmetallic N/C nanozyme performs continuous consumption of glu
for inhibition of colorectal cancer cells. ACS Appl Bio Mater.
6:267–276. 2023. View Article : Google Scholar
|
|
211
|
Jin Y, Zhang J, Xu Y, Yi K, Li F, Zhou H,
Wang H, Chan HF, Lao YH, Lv S, et al: Stem cell-derived hepatocyte
therapy using versatile biomimetic nanozyme incorporated
nanofiber-reinforced decellularized extracellular matrix hydrogels
for the treatment of acute liver failure. Bioact Mater. 28:112–131.
2023.PubMed/NCBI
|
|
212
|
Sahu A, Jeon J, Lee MS, Yang HS and Tae G:
nanozyme impregnated mesenchymal stem cells for hepatic
ischemia-reperfusion injury alleviation. ACS Appl Mater Interfaces.
13:25649–25662. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
213
|
Wang Z, Liu H, Yang SH, Wang T, Liu C and
Cao YC: Nanoparticle-based artificial RNA silencing machinery for
antiviral therapy. Proc Natl Acad Sci USA. 109:12387–12392. 2012.
View Article : Google Scholar : PubMed/NCBI
|
